Stereotaxis is a global leader in developing innovative surgical robotics for minimally invasive endovascular intervention. Its mission is to discover, develop, and deliver robotic systems, instruments, and information solutions for the interventional laboratory. These innovations are designed to help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance productivity, connectivity, and intelligence in the operating room. The Stereotaxis system has helped physicians expand access to minimally invasive therapy and enhance productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 100,000 patients across the United States, Europe, Asia, and other parts of the world. Broward Health Medical Center in Fort Lauderdale, Florida has become the first hospital in the state to offer the Genesis Robotic Magnetic Navigation System to treat heart rhythm disorders. The system, developed by Stereotaxis, introduces the benefits of robotic precision and safety to cardiac ablation, a common, minimally invasive procedure to treat arrhythmias.
Broward Health Medical Center in Fort Lauderdale, Florida has become the first hospital in the state to offer the Genesis Robotic Magnetic Navigation System to treat heart rhythm disorders. The system, developed by Stereotaxis, a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, introduces the benefits of robotic precision and safety to cardiac ablation, a common, minimally invasive procedure to treat arrhythmias. The Genesis RMN system will allow Broward Health to expand their electrophysiology capabilities to treat complex heart arrhythmias with heightened precision. The Stereotaxis system aims to improve patient outcomes and reduce radiation exposure. Tens of millions of individuals worldwide suffer from arrhythmias, which can significantly increase the risk of stroke, heart failure, and sudden cardiac arrest if left untreated. Broward Health is committed to adopting innovative technology to make it available to patients close to home, said Shane Strum, President & CEO of Broward Health. David Fischel, Chairman and CEO of Stereotaxis, applauded Broward Health’s leadership and expressed his delight to work with them as they pioneer this technology for the benefit of patients in Florida.
Stereotaxis (NYSE: STXS) is a global leader in developing innovative surgical robotics for minimally invasive endovascular intervention. Its mission is to discover, develop, and deliver robotic systems, instruments, and information solutions for the interventional laboratory. These innovations are designed to help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance productivity, connectivity, and intelligence in the operating room. Stereotaxis has already treated over 100,000 patients across the United States, Europe, Asia, and other parts of the world using its advanced technology.
Stereotaxis has become a key player in the surgical robotics industry and has created a name for itself by providing state-of-the-art medical technology to physicians and hospitals around the world. The company has also been able to provide physicians with a high level of precision and safety through its robotic systems, which offer many benefits over traditional surgical methods. By leveraging robotic technology, surgeons can perform complex medical procedures with increased accuracy, safety, and efficiency.
The Stereotaxis system has helped physicians expand access to minimally invasive therapy and enhance productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 100,000 patients across the United States, Europe, Asia, and other regions of the world. The company’s innovative systems have enabled physicians to deliver unprecedented levels of precision and safety while performing complex medical procedures.
Stereotaxis has a wide range of products designed to help physicians provide better care to their patients. Some of its products include robotic systems, instruments, and information solutions for the interventional laboratory. The company has worked hard to create a name for itself by providing cutting-edge medical technology to physicians and hospitals around the world. Stereotaxis is dedicated to improving patient outcomes and helping physicians provide better care.
By leveraging robotic technology, Stereotaxis aims to change the future of surgery and medical treatment. The company has already made significant strides in this area, and it will undoubtedly continue to make even greater advances in the years to come. Stereotaxis has a bright future ahead of it, and it will continue to lead the way in surgical robotics for years to come.
Don’t miss interesting posts on Famousbio
